In addition, one in vivo study [70] showed that decreasing POSTN levels in pancreatic cancer cells inhibited tumor growth, reduced VEGF expression, and reduced angiogenesis and metastasis in mouse models. This evidence concerns the gene VEGFA and pancreatic neoplasm.